Valuing Out-of-Pocket Expenditure and Health Related Quality of Life of COVID-19 patients from Gujarat, India

  • Priya Kotwani Assistant Professor, Parul Institute of Public Health, Parul University, Waghodia, Vadodara, Gujarat, India. https://orcid.org/0000-0001-9049-0696
  • Vaibhav Patwardhan Assistant Professor, Parul Institute of Public Health, Parul University, Waghodia, Vadodara, Gujarat, India.
  • Apurvakumar Pandya Economic Evaluation Specialist, Regional Resource Centre for Health Technology Assessment, IIPH, Gandhinagar, Gujarat, India.
  • Somen Saha Associate Professor, IIPH, Gandhinagar, Gujarat, India; and Adjunct Faculty, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha, Maharashtra, India.
  • Geetika Madan Patel Associate Professor, Parul Institute of Medical Science and Research, Parul University, Waghodia, Vadodara, Gujarat, India.
  • Sachin Jaiswal MPH Student, Parul Institute of Public Health, Parul University, Waghodia, Vadodara, Gujarat, India.
  • Zinal Trivedi MPH Student, Parul Institute of Public Health, Parul University, Waghodia, Vadodara, Gujarat, India.
Keywords: Out-of-Pocket Expenditure, EQ-5D-5L, Health Related Quality of Life, COVID-19

Abstract

Background: COVID-19 has financially burdened Government’s healthcare system as well as households with COVID-19 patients. Present study aims to value the out-of-pocket expenditure and health-related quality of life (HRQOL) using EQ-5D-5L among COVID-19 patients who sought treatment in COVID-19 center of a tertiary hospital in Vadodara, Gujarat.

Methods: The present analysis is a prospective real-world study. The questionnaire included socio-demographic data, health status, out-of-pocket expenses associated with treatment of COVID-19, and EQ-5D-5L scale. The relationships of all factors and the scores of EQ-5D-5L were analyzed. All costs are reported in Indian Rupees and then converted to US dollars.

Result: Out of total 138 participants included in the study, 108 (78.3%) participants had mild to moderate symptoms of COVID-19 infection and were admitted to COVID Care Centre (CCC) while 30 (21.7%) patients had severe disease and were admitted to COVID Intensive Care Unit (ICU). Mean total out of pocket expenditure for the patient admitted to COVID CCC and COVID ICU was INR 11,333.07 (31,707.68) and 27,374.17 (54,205.72) respectively. The respondents obtained a mean EQ-5D-5L index score of 0.755 (±0.180) for patients under COVID CCC and 0.513 (±0.378) for COVID ICU admitted patients. EQ-VAS index was 75.05 (±12.12) and 62 (±16.37) respectively, signifying the HRQoL from patient’s perspective.

Conclusion: COVID-19 patients have suffered from significant physical and psychological impairment. It is essential to prospectively monitor the individuals who suffered from COVID-19 to understand the long term impact on HRQoL, as well as to inform prompt and efficient interventions to alleviate suffering.

How to cite this article:
Kotwani P, Patwardhan V, Pandya A, Saha S, Patel GM, Jaiswal S et al. Valuing Out-of-Pocket Expenditure and Health Related Quality of Life of COVID-19 Patients from Gujarat, India. J Commun Dis 2021; 53(1): 104-109.

DOI: https://doi.org/10.24321/0019.5138.202117

Author Biographies

Apurvakumar Pandya, Economic Evaluation Specialist, Regional Resource Centre for Health Technology Assessment, IIPH, Gandhinagar, Gujarat, India.

Economic Evaluation Specialist

Somen Saha, Associate Professor, IIPH, Gandhinagar, Gujarat, India; and Adjunct Faculty, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha, Maharashtra, India.

Associate Professor

References

Regulate fees of private hospitals treating Covid-19 patients: Gujarat HC | Ahmedabad News - Times of

India, 2020. Available from: https://timesofindia.indiatimes.com/city/ahmedabad/regulate-fees-ofprivate-

hospitals-treating-covid-19-patients-gujarat-hc/articleshow/75763110.cms.

Free treatment in 31 COVID-19 hospitals: Gujarat Government, Cities News, The Indian Express, 2020.

Available from: https://indianexpress.com/article/cities/ahmedabad/free-treatment-in-31-covid-19-

hospitals-gujarat-govt-6367255/.

Vaillancourt F. COVID-19 and the health policy recession: whatever it takes, grandma or the economy or what

makes sense? CIRANO, 2020.

Archer SL. Providing care for the 99.9% during the COVID-19 pandemic: How ethics, equity, epidemiology,

and cost per QALY inform healthcare policy. Healthc Manag Forum 2020.

EuroQol Research Foundation. EQ-5D-5L User Guide, 2019. 2019; 36. Available from: https://euroqol.org/

publications/user-guides/.

Department of Health Research. Health Technology Assessment in India. Ministry of Health & Family

Welfare, Government of India, New Delhi. 2018.

Drummond MF, Sculpher MJ, Claxton K et al. Methods for the economic evaluation of health care programmes.Oxford University Press, 2015.

Saikia N. Gender disparities in health care expenditures and financing strategies (HCFS) for inpatient care in

India. SSM-Population Health 2019; 9: 100372.

Archer SL. Providing care for the 99.9% during the COVID-19 pandemic: How ethics, equity, epidemiology,

and cost per QALY inform healthcare policy. InHealthcare Management Forum, 2020. SAGE Publications, Los

Angeles, CA.

Pandey A, Ploubidis GB, Clarke L et al. Trends in catastrophic health expenditure in India: 1993 to 2014.

Bulletin of the World Health Organization 2018; 96(1): 18.

Ministry of Health and Family Welfare. National Health Policy 2017. New Delhi: Government of India. Available

from https://www.nhp.gov.in/nhpfiles/national_health_policy_2017.pdf.

Benning TM, Alayli-Goebbels AF, Aarts MJ et al. Exploring outcomes to consider in economic evaluations

of health promotion programs: what broader nonhealth outcomes matter most? BMC Health Services

Research 2015; 15(1): 266.

Murphy A, McGowan C, McKee M et al. Coping with healthcare costs for chronic illness in low-income

and middle-income countries: a systematic literature review. BMJ Global Health 2019; 4(4): e001475.

Garrigues E, Janvier P, Kherabi Y et al. Post-discharge persistent symptoms and health-related quality of

life after hospitalization for COVID-19. J Infect 2020; S0163-4453(20): 30562-4.

Published
2021-03-31